Actavis Products transferring to Teva
Teva Pharmaceuticals has completed its global acquisition of Allergan’s generics business (Actavis Generics in Ireland) following approval by the European Competition Authority.
The terms of the acquisition will see Teva take responsibility for over 100 new product lines in Ireland that will be integrated with our existing portfolio. To that end, we have created this dedicated website that includes information on all of the products transferring from Actavis Ireland to Teva Ireland. In addition, our representatives are available to respond to any queries you might have. Finally, I would like to take this opportunity to thank you for your continued support. I look forward to continuing to work closely with you in the future.
Sandra Gannon, General Manager
NEW TO TEVA
This is a trade only information site from Teva Ireland & Actavis Ireland to provide assistance to customers & prescribers in product transition www.teva.ie © 2016
Teva Pharmaceutical Industries Ltd (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by millions of patients every day.
Teva is the world's largest generic medicines producer, with a portfolio of more than 1,000 molecules to produce a wide range of generic products in almost every therapeutic area.